Publications
5674 Results
- Journal / Conference
- Journal of Clinical Oncology 27(1):114-119
- Year
- 2009
- Research Committee(s)
- Lymphoma
- Study Number(s)
- SWOG-8516 (INT-0067)
Natural history of central nervous system (CNS) relapse in patients with aggressive non-hodgkin's lymphoma: a 20 year follow-up analysis of SWOG 8516 -- the Southwest Oncology Group [PMID19047289]
- Journal / Conference
- Journal of Clinical Oncology 27(15):2450-2456
- Year
- 2009
- Research Committee(s)
- Genitourinary
- Study Number(s)
- SWOG-9346, S9916
Prostate-specific antigen progression (PSA-P) predicts overall survival (OS) in patients with metastatic prostate cancer: data from Southwest Oncology Group (SWOG) trials 9346 (INT 0162) and 9916 [PMC2684851; PMID19380444]
- Journal / Conference
- Journal of Urology 181(6):2476-2480
- Year
- 2009
- Research Committee(s)
- Genitourinary
- Study Number(s)
- S0219
A sequential treatment approach to myoinvasive urothelial cancer: a phase II Southwest Oncology Group Trial (S0219) [PMC2769926; PMID1937909]
- Journal / Conference
- Journal of Clinical Oncology 27(17):2848-2854
- Year
- 2009
- Research Committee(s)
- Gastrointestinal
- Study Number(s)
- N9841
A randomized phase III non-inferiority trial of irinotecan (CPT-11) versus oxaliplatin (OXAL)/5-fluorouracil (5-FU)/leucovorin (CF) in patients with advanced colorectal carcinoma previously treated with 5-FU, N9841 [PMC2698019; PMID19380443]
- Journal / Conference
- Journal of Clinical Oncology 27(16):2638-2644
- Year
- 2009
- Research Committee(s)
- Breast
- Study Number(s)
- N9831
Radiotherapy and adjuvant trastuzumab in operable breast cancer: tolerability and adverse event data from the North Central Cancer Treatment Group Phase 3 trial (N9831) [PMC2690390; PMID19349549]
- Journal / Conference
- ASCO 2009 GU Cancers Symposium, abst. #249
- Year
- 2009
- Research Committee(s)
- Genitourinary
- Study Number(s)
- SWOG-8710 (INT-0080) (EST-1887) (CALGB-8891)
Quality of pathologic response and surgery correlate with survival for completely resected bladder cancer following neoadjuvant MVAC
- Journal / Conference
- Journal of the American Medical Association 301(1)39-51
- Year
- 2009
- Research Committee(s)
- Prevention, Screening, and and Surveillance
- Study Number(s)
- S0000
Effect of selenium and vitamin E on risk of prostate cancer and other cancers: The Selenium and Vitamin E Cancer Prevention Trial (SELECT). PMID:19066370; PMC3682779
- Journal / Conference
- American Urological Association 2009 Annual Meeting, abstract #1747, poster presentation
- Year
- 2009
- Research Committee(s)
- Genitourinary
- Study Number(s)
- 4B951
Variability in surgical quality in a randomized clinical trial of adjuvant chemotherapy following radical cystectomy and pelvic lymphadenectomy
- Journal / Conference
- Journal of Clinical Oncology 27(15):2530-2535
- Year
- 2009
- Research Committee(s)
- Lung
- Study Number(s)
- S0124
Phase III trial of irinotecan/cisplatin compared with etoposide/cisplatin in extensive small-cell lung cancer: clinical and pharmacogenomic results from SWOG S0124 [PMID19349543; PMC2684855]
- Journal / Conference
- Journal of Urology 181(3):956-962
- Year
- 2009
- Research Committee(s)
- Genitourinary
- Study Number(s)
- SWOG-8794